EP2582798A1 - Herstellung von biodiesel mittels hefe aus lignocellulose und glycerin - Google Patents
Herstellung von biodiesel mittels hefe aus lignocellulose und glycerinInfo
- Publication number
- EP2582798A1 EP2582798A1 EP11725783.2A EP11725783A EP2582798A1 EP 2582798 A1 EP2582798 A1 EP 2582798A1 EP 11725783 A EP11725783 A EP 11725783A EP 2582798 A1 EP2582798 A1 EP 2582798A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- seq
- gene
- fatty acids
- yeast
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title claims abstract description 141
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 50
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 181
- 239000003225 biodiesel Substances 0.000 title abstract description 27
- 244000005700 microbiome Species 0.000 claims abstract description 52
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 47
- 239000001963 growth medium Substances 0.000 claims abstract description 47
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 45
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 38
- 239000008103 glucose Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 28
- 101710153103 Long-chain-fatty-acid-CoA ligase FadD13 Proteins 0.000 claims abstract description 24
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 21
- 150000002148 esters Chemical class 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 9
- 230000002829 reductive effect Effects 0.000 claims abstract description 9
- 239000008107 starch Substances 0.000 claims abstract description 9
- 235000019698 starch Nutrition 0.000 claims abstract description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 179
- 108090000623 proteins and genes Proteins 0.000 claims description 123
- 102000004169 proteins and genes Human genes 0.000 claims description 78
- 230000002538 fungal effect Effects 0.000 claims description 49
- 238000012217 deletion Methods 0.000 claims description 36
- 230000037430 deletion Effects 0.000 claims description 36
- 241000894007 species Species 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 101150098284 FAA2 gene Proteins 0.000 claims description 26
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 24
- 230000014509 gene expression Effects 0.000 claims description 24
- 108010008221 formate C-acetyltransferase Proteins 0.000 claims description 20
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 claims description 19
- 108010018763 Biotin carboxylase Proteins 0.000 claims description 19
- 101150058703 ACC1 gene Proteins 0.000 claims description 14
- 241000222178 Candida tropicalis Species 0.000 claims description 14
- 108700019146 Transgenes Proteins 0.000 claims description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 13
- 239000001301 oxygen Substances 0.000 claims description 13
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 claims description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 12
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 12
- 108020002982 thioesterase Proteins 0.000 claims description 12
- 102000005488 Thioesterase Human genes 0.000 claims description 11
- 101150086278 fdh gene Proteins 0.000 claims description 11
- -1 formate hydrogen Chemical class 0.000 claims description 11
- 241000223252 Rhodotorula Species 0.000 claims description 10
- 230000001086 cytosolic effect Effects 0.000 claims description 10
- 102000057621 Glycerol kinases Human genes 0.000 claims description 8
- 108700016170 Glycerol kinases Proteins 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 238000012224 gene deletion Methods 0.000 claims description 8
- 108090000698 Formate Dehydrogenases Proteins 0.000 claims description 7
- 241000235070 Saccharomyces Species 0.000 claims description 7
- 108700040099 Xylose isomerases Proteins 0.000 claims description 7
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 6
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 240000006053 Garcinia mangostana Species 0.000 claims description 6
- 241000235013 Yarrowia Species 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 5
- 241001527609 Cryptococcus Species 0.000 claims description 5
- 241000048017 Cyberlindnera Species 0.000 claims description 5
- 241000235035 Debaryomyces Species 0.000 claims description 5
- 241000223218 Fusarium Species 0.000 claims description 5
- 229920002488 Hemicellulose Polymers 0.000 claims description 5
- 241001149698 Lipomyces Species 0.000 claims description 5
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims description 5
- 241000235395 Mucor Species 0.000 claims description 5
- 241000235652 Pachysolen Species 0.000 claims description 5
- 241000235647 Pachysolen tannophilus Species 0.000 claims description 5
- 241000235648 Pichia Species 0.000 claims description 5
- 241000235527 Rhizopus Species 0.000 claims description 5
- 241000223230 Trichosporon Species 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 108010034895 formate hydrogenlyase Proteins 0.000 claims description 5
- 150000005846 sugar alcohols Chemical class 0.000 claims description 5
- 229920001221 xylan Polymers 0.000 claims description 5
- 150000004823 xylans Chemical class 0.000 claims description 5
- 101710120269 Acyl-CoA thioester hydrolase YbgC Proteins 0.000 claims description 4
- 102100025854 Acyl-coenzyme A thioesterase 1 Human genes 0.000 claims description 4
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 4
- 240000002791 Brassica napus Species 0.000 claims description 4
- 241001495477 Cuphea wrightii Species 0.000 claims description 4
- 101000720368 Homo sapiens Acyl-coenzyme A thioesterase 1 Proteins 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 235000011293 Brassica napus Nutrition 0.000 claims description 3
- 244000020518 Carthamus tinctorius Species 0.000 claims description 3
- 241000195597 Chlamydomonas reinhardtii Species 0.000 claims description 3
- 241000193403 Clostridium Species 0.000 claims description 3
- 240000006262 Cuphea hookeriana Species 0.000 claims description 3
- 241000700157 Rattus norvegicus Species 0.000 claims description 3
- 240000000528 Ricinus communis Species 0.000 claims description 3
- 235000004443 Ricinus communis Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 102000057234 Acyl transferases Human genes 0.000 claims description 2
- 108700016155 Acyl transferases Proteins 0.000 claims description 2
- 108090000856 Lyases Proteins 0.000 claims description 2
- 102000004317 Lyases Human genes 0.000 claims description 2
- 101100236714 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) EEB1 gene Proteins 0.000 claims description 2
- 101150067366 adh gene Proteins 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 203
- 239000000194 fatty acid Substances 0.000 abstract description 203
- 229930195729 fatty acid Natural products 0.000 abstract description 203
- 150000004665 fatty acids Chemical class 0.000 abstract description 202
- 239000002609 medium Substances 0.000 abstract description 43
- 150000002632 lipids Chemical class 0.000 abstract description 22
- 230000015572 biosynthetic process Effects 0.000 abstract description 19
- 230000037353 metabolic pathway Effects 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 6
- 235000003869 genetically modified organism Nutrition 0.000 abstract description 2
- 101100127690 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA2 gene Proteins 0.000 description 38
- 238000000855 fermentation Methods 0.000 description 28
- 230000012010 growth Effects 0.000 description 28
- 101150050575 URA3 gene Proteins 0.000 description 27
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 27
- 230000004151 fermentation Effects 0.000 description 27
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 24
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 19
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 16
- 230000028327 secretion Effects 0.000 description 16
- 210000000172 cytosol Anatomy 0.000 description 14
- 239000012071 phase Substances 0.000 description 13
- 230000003834 intracellular effect Effects 0.000 description 12
- 150000004667 medium chain fatty acids Chemical class 0.000 description 12
- 238000011144 upstream manufacturing Methods 0.000 description 12
- 150000004669 very long chain fatty acids Chemical class 0.000 description 12
- 101710190443 Acetyl-CoA carboxylase 1 Proteins 0.000 description 11
- 102100021334 Bcl-2-related protein A1 Human genes 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 10
- 235000021314 Palmitic acid Nutrition 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000004907 flux Effects 0.000 description 9
- 230000014759 maintenance of location Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 9
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 8
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 8
- 101150001810 TEAD1 gene Proteins 0.000 description 8
- 101150074253 TEF1 gene Proteins 0.000 description 8
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 8
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 108010078791 Carrier Proteins Proteins 0.000 description 7
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 7
- 150000001335 aliphatic alkanes Chemical class 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000004817 gas chromatography Methods 0.000 description 7
- 238000003306 harvesting Methods 0.000 description 7
- 150000004668 long chain fatty acids Chemical class 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 210000005253 yeast cell Anatomy 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000009603 aerobic growth Effects 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006114 decarboxylation reaction Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000004136 fatty acid synthesis Effects 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000002018 overexpression Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- KMXFZRSJMDYPPG-UHFFFAOYSA-N tetratetracontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC KMXFZRSJMDYPPG-UHFFFAOYSA-N 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- SEHFUALWMUWDKS-UHFFFAOYSA-N 5-fluoroorotic acid Chemical compound OC(=O)C=1NC(=O)NC(=O)C=1F SEHFUALWMUWDKS-UHFFFAOYSA-N 0.000 description 5
- 241001042096 Cyberlindnera tropicalis Species 0.000 description 5
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 5
- 239000006481 glucose medium Substances 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 210000002824 peroxisome Anatomy 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 229940076788 pyruvate Drugs 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 4
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 4
- 241000351920 Aspergillus nidulans Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 108091092584 GDNA Proteins 0.000 description 4
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 4
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 4
- 241000235058 Komagataella pastoris Species 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000000446 fuel Substances 0.000 description 4
- 230000034659 glycolysis Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 241000256844 Apis mellifera Species 0.000 description 3
- 238000006611 Barton decarboxylation reaction Methods 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 238000006576 Kolbe electrolysis reaction Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 241000235015 Yarrowia lipolytica Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000009604 anaerobic growth Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 150000002185 fatty acyl-CoAs Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000005648 named reaction Methods 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 150000002972 pentoses Chemical class 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 2
- 101100367244 Arabidopsis thaliana SWA1 gene Proteins 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 101150041653 FAA3 gene Proteins 0.000 description 2
- 101150107660 FAA4 gene Proteins 0.000 description 2
- 108010058732 Fatty Acid Elongases Proteins 0.000 description 2
- 102000036181 Fatty Acid Elongases Human genes 0.000 description 2
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 2
- 101150009006 HIS3 gene Proteins 0.000 description 2
- 101000959452 Homo sapiens Alcohol dehydrogenase class-3 Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 101150014136 SUC2 gene Proteins 0.000 description 2
- 101100127688 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA1 gene Proteins 0.000 description 2
- 101100127691 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA3 gene Proteins 0.000 description 2
- 101100127692 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA4 gene Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000001925 catabolic effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000008723 osmotic stress Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- NKTGCVUIESDXPU-YLEPRARLSA-N triacsin C Chemical compound CCC\C=C\C\C=C\C=C\C=N\NN=O NKTGCVUIESDXPU-YLEPRARLSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- ANXOZVKTXWJGOY-UHFFFAOYSA-N 2-aminoethanone Chemical compound NC[C]=O ANXOZVKTXWJGOY-UHFFFAOYSA-N 0.000 description 1
- GFPWJSLXWAXUIN-UHFFFAOYSA-N 2-butoxyethyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CCCCOCCOC(=O)C1C(C=C(Cl)Cl)C1(C)C GFPWJSLXWAXUIN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 108700037654 Acyl carrier protein (ACP) Proteins 0.000 description 1
- 102000048456 Acyl carrier protein (ACP) Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100011518 Arabidopsis thaliana ELP1 gene Proteins 0.000 description 1
- 101100225658 Arabidopsis thaliana ELP4 gene Proteins 0.000 description 1
- 101100172211 Arabidopsis thaliana HAG3 gene Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 101150076489 B gene Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 101100268665 Caenorhabditis elegans acc-1 gene Proteins 0.000 description 1
- 101100012567 Caenorhabditis elegans fat-1 gene Proteins 0.000 description 1
- 101100351811 Caenorhabditis elegans pgal-1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 240000004439 Cistus albidus Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 241000065719 Crocosphaera Species 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000235036 Debaryomyces hansenii Species 0.000 description 1
- 241000199920 Ectocarpus Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 101150039661 FAA1 gene Proteins 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000884385 Homo sapiens Arylamine N-acetyltransferase 1 Proteins 0.000 description 1
- 101000824318 Homo sapiens Protocadherin Fat 1 Proteins 0.000 description 1
- 238000007241 Hunsdiecker-Borodin reaction Methods 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241001501885 Isochrysis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001149691 Lipomyces starkeyi Species 0.000 description 1
- 241000218397 Magnolia x soulangeana Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004165 Methyl ester of fatty acids Substances 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 241000306281 Mucor ambiguus Species 0.000 description 1
- 241000907556 Mucor hiemalis Species 0.000 description 1
- 241000235526 Mucor racemosus Species 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- MAEYQWMXLXNZQO-UHFFFAOYSA-N OCC(C=O)OP(=O)=O Chemical compound OCC(C=O)OP(=O)=O MAEYQWMXLXNZQO-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100022095 Protocadherin Fat 1 Human genes 0.000 description 1
- 241001491792 Prymnesium Species 0.000 description 1
- 241000005867 Puya angusta Species 0.000 description 1
- 108010090051 Pyruvate Dehydrogenase Complex Proteins 0.000 description 1
- 102000012751 Pyruvate Dehydrogenase Complex Human genes 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241000221523 Rhodotorula toruloides Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 101100118655 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ELO1 gene Proteins 0.000 description 1
- 101100501248 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ELO2 gene Proteins 0.000 description 1
- 101100501251 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ELO3 gene Proteins 0.000 description 1
- 244000253911 Saccharomyces fragilis Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- 241000235060 Scheffersomyces stipitis Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000908909 Streblonema Species 0.000 description 1
- 241001634922 Tausonia pullulans Species 0.000 description 1
- 101000972444 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 241001414833 Triatoma Species 0.000 description 1
- 241001414831 Triatoma infestans Species 0.000 description 1
- 241000258236 Zootermopsis angusticollis Species 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940099983 activase Drugs 0.000 description 1
- XNBFNPXGEIQVBJ-HUBRGWSESA-N adenosine 5'-hexadecylphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OCCCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 XNBFNPXGEIQVBJ-HUBRGWSESA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000004099 anaerobic respiration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000012769 bulk production Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000003197 gene knockdown Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010565 inoculated fermentation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000858 peroxisomal effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/649—Biodiesel, i.e. fatty acid alkyl esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- Biodiesel refers to a fuel comprised of mono-alkyl esters of long chain fatty acids derived from vegetable oils or animal fats, designated B100, and meeting the requirements of ASTM D 6751 .
- B100 mono-alkyl esters of long chain fatty acids derived from vegetable oils or animal fats
- ASTM D 6751 the most common method of Biodiesel production is trans-esterification of edible and non-edible vegetable oils, or sometimes animal fats.
- the trans-esterification reaction transforms triglycerides into fatty acid alkyl ester, in the presence of an alcohol, such as methanol or ethanol, and a catalyst, such as an alkali or acid, where glycerol is a by-product.
- the genetically modified microorganism is characterised by comprising a transgene encoding a pyruvate formate lyase comprising PflA and PflB.
- the genetically modified microorganism may be further characterised by additionally comprising a transgene encoding an acyl CoA-ACP thioesterase, wherein said thioesterase is selected from among: Soyabean (Glycine max Chlamydomonas reinhardtii (Protein ID - A8HY17); Arabidopsis thaliana (Protein ID - Q9SJE2); Ricinus communis (Protein ID - B9RAC3); Triticum aestivum; CtFatA from Brassica napus (Protein ID - Q43745); CtFatA from C. tinctorius (Protein ID - Q42715); GmFatAI from G.
- Soyabean Glycine max Chlamydomonas reinhardtii (Protein ID - A8HY17); Arabidopsis thaliana (Protein ID - Q9SJE2); Ricinus communis (Prot
- the genetically modified microorganism may be further characterised by additionally comprising enhanced expression of an acyl-coenzymeA:ethanol O-acyltransferase conferred by a recombinant endogenous acyl- coenzymeA:ethanol O-acyltransferase (EEB1 ) gene wherein said gene is operably linked to a heterologous promoter.
- EEB1 endogenous acyl- coenzymeA:ethanol O-acyltransferase
- the growth medium of the method comprises a carbon source is selected from at least one of glucose, glycerol, xylose, hydrolysed cellulose and hemicellulose, starch, sugar alcohol and xylan, Preferably the growth medium comprises or consists of the components set out below.
- the present invention is also provides a growth medium adapted for use in the above described method, wherein the medium the composition comprises the following components,
- Component Composition (grams/litre)
- Figure 1a Saponifiable fatty acid content of two yeast strains (Y axis) as a function of fermentation growth temperature (X-axis). Note that the values of control reading are on X axis with Y co-ordinate as zero throughout the experiment.
- Figure 1 b Saponifiable fatty acid content of two yeast strains (Y axis) as a function of glucose concentration (X-axis). The relationship is linear passing through origin, however, due to practical difficulties, the trend was
- Figure 2 Gas Chromatogram of methyl esters of fatty acids secreted into the medium by yeast strain Saccharomyces cerevisiae (Wild type).
- Figure 3 Lipid metabolic cycle in yeast, a) FAA2 is one of the enzymes in the repertoire of Saccharomyces cerevisiae which catalyzes the first step involved in catabolism of fatty acids; b) manipulation of the lipid metabolism in yeast.
- Figure 5 SDS-gel with PCR amplification products of FAA2 from WT genome.
- Lane 1 DNA size marker:100 - 10,000 nucleotide base pairs;
- Lane 2 PCR product of WT yeast genomic DNA amplification using primer pair 3 (Table 4).
- Figure 6a,b Detection of FAA2 (Aura3) deletion in gDNA from transformed yeast colonies.
- Wells 3-9, 1 1 -17 contain genomic DNA from transformed yeast colonies, amplified with FAA2 primer set 3.
- Wells 18, 20-27, 30-33 contain genomic DNA from transformed yeast colonies, amplified with URA3 primer set 2.
- Wells 1 , 10, 19, 28, 29, 40 contain DNA size ladders.
- Well number 2 and 39 contained WT-DNA amplified with primer set 3 and primer set 2 respectively.
- Well 38 contain URA3 plasmid amplified with primer set 2, as positive control.
- Figure 7 GC-MS graph of extracellular fatty acids secreted by from WT- strain (S. cerevisiae) grown on glucose medium.
- Figure 8 GC-MS graph of intracellular fatty acids secreted by from WT-strain (S. cerevisiae) grown on glucose medium.
- Figure 9 GC-MS graph of extracellular fatty acids by FAA2 (Aura3) deletion mutant of WT-strain (S. cerevisiae FAA2 Aura3) grown on glucose medium.
- Figure 10 GC-MS graph of intracellular fatty acids by FAA2 (Aura3) deletion mutant of WT-strain (S. cerevisiae FAA2 Aura3) grown on glucose medium.
- Figure 11 GC-MS graph of extracellular fatty acids secreted by from WT- strain (S. cerevisiae) grown on glycerol medium.
- Figure 12 GC-MS graph of extracellular fatty acids by FAA2 (Aura3) deletion mutant of WT-strain (S. cerevisiae FAA2 Aura3) grown on glycerol medium.
- Figure 13 GC-MS graph of extracellular fatty acids by Candida tropicalis grown on glucose medium (upper panel); fatty acid standards (lower panel).
- Figure 14 GC-MS graph of extracellular fatty acids by Candida tropicalis grown on glycerol medium (upper panel); fatty acid standards (lower panel).
- Figure 15 The homologous recombination of upstream and downstream sequences from the bipartite gene-targeting substrate to the chromosomal locus results in the exchange of ACC1 promoter to TEF1 promoter and the insertion of Kl URA3 flanked by direct repeats (DR). The Kl URA3 was later removed by plating the strains on medium containing 5-fluoroorotic acid (5- FOA).
- 5- FOA 5-fluoroorotic acid
- Figure 16 PCR detection of FAA2 (Aura3) deletion in gDNA from transformed SC-ACC1 yeast colonies.
- Lane 1 -4 contain genomic DNA from transformed yeast colonies, amplified with FAA2 primer set 3 and URA3 primers respectively, and demonstrate presence of URA3 and absence of FAA2 in the gDNA in mutants in Lanes 1 , 2 and 4.
- Lane 5 contains a DNA size ladder.
- Figure 17 PCR detection of E.coli pyruvate formate lyase A gene (in lane 1 and 4) and Pyruvate Formate lyase B gene (in lane 2 and 3) amplified from E.coli genome, amplified with pfIA and pfIB specific primers. Lane M contains a DNA size ladder.
- Figure 18 Gel Photograph showing plasmid (in lane 2 and 3) and ligated plasmid (in lane 1 and 4).
- the lane 1 is PfIA gene in shuttle vector PCM182.
- the lane 4 is PFLB gene in shuttle vector PCM183.
- Lane M contains a DNA size ladder.
- Figure 19 Comparative fatty acid yield of yeast strains of invention when grown on 20% glucose as carbon source.
- Figure 20 Comparative fatty acid yield of yeast strains of invention when grown 5% pure glycerol as carbon source.
- Figure 21 Comparative fatty acid yield of yeast strains of invention when grown on 5% crude glycerol as carbon source.
- Figure 22 Comparative fatty acid yield of yeast strains of invention when grown on 15% xylose as carbon source
- Figure 23 Comparative fatty acid yield of yeast strains of invention when grown on 10ml/L hydrolysed wheat kignocellulose as carbon source
- FAA2 - gene encoding long chain fatty acyl-CoA synthetase (Faa2p; EC No: 6.2.1 .3) that accepts a wider range of acyl chain lengths than Faal p, preferring C9:0-C13:0; and is involved in the activation of endogenous pools of fatty acids;
- the microorganism of the invention is a yeast or fungal species, since yeast and fungi can accumulate oils under some cultivation conditions, and some yeast and fungi species secrete fatty acids into the medium when grown on certain carbon sources. Accordingly, a yeast or fungal species of the invention is one that is able to secrete fatty acids extracellularly in the medium, and is capable of producing a large cell biomass combined with and a high extracellular lipid yield.
- a preferred yeast or fungal species according to the invention is a yeast or fugal species capable of secreting fatty acids and esters thereof, said yeast or fungal species belonging to the genus Aspergillus (e.g. A.
- Candida e.g. C. tropicalis; C. magnolia
- Cryptococcus e.g. C. albidus
- Debaryomyces e.g. D. hansenii
- Fusarium e.g. F. oxysporum
- Lindnera e.g. L. jadinii
- Lipomyces e.g. L. lipofera or L. starkeyi
- Monascus e.g. M. purpureus
- Mucor e.g.; M. circinelloides, M. hiemalis; M. miehei; M. racemosus
- Pachysolen e.g. P. tannophilus
- Pichia e.g. P. P.
- the micro-organism is a Saccharomyces, in particular S. cerevisiae.
- the microorganism belongs to the yeast genus Candida, in particular the species Candida tropicalis, said yeast being characterised by the secretion of palmitic acid.
- yeast genus Candida in particular the species Candida tropicalis, said yeast being characterised by the secretion of palmitic acid.
- a genetically modified yeast or fungal species/strain of the invention is preferably derived from a microorganism selected from the group set out above under section I.
- One or more gene controlling the metabolic pathways in the selected yeast or fungal species/strain is genetically modified to enable the selected species/strain to produce and secrete esters of fatty acids from various cheap carbon sources such as starch, glycerol and lignocellulose.
- a yeast or fungal species/strain of the invention carries a deletion in the FAA2 gene (FAA2A strain) encoding the Faa2p, which catalyses the activation of medium-chain fatty acids, being the first committed step in beta-oxidation of these fatty acids. Deletion of FAA2 gene, in the yeast or fungal species, reduces the metabolic flux through fatty acid catabolism.
- a FAA2A yeast or fungal species of the invention is characterised, not only by the synthesis of a surprisingly higher proportion of MCFAs than wild type yeast, but as further being capable of extracellular secretion of the MCFAs synthesized within the cell.
- the deleted FAA2 gene is Gene ID: 856734 (SEQ ID No: 1 ) and encodes FAA2 (EC 6.2.1 .3) having protein ID: P39518 (SEQ ID No: 2).
- 2.1 .2 Silencing endogenous fatty acyl CoA synthetase gene expression
- expression of the one or more endogenous fatty acyl-CoA synthetase (FAA) genes in the yeast or fungal species of the invention is silenced or knocked-down by means of gene deletion or by means of promoter engineering.
- FAA fatty acyl-CoA synthetase
- promoters of each of the S. cerevisiae, FAA1 , FAA3, FAA4 may be substituted with promoters driving lower expression levels.
- a corresponding strategy may be applied to silence or knock-down the expression of FAA genes in other yeast species.
- the FAA gene to be silenced by gene deletion or knocked out by means of promoter engineering is one or more of the Faa1 gene (GenelD: 854495 (SEQ ID No: 3); encoding Protein ID - P30624: (SEQ ID No: 4)); the Faa3 gene (GenelD: 854808 (SEQ ID No: 5) encoding Protein ID - P39002 (SEQ ID No: 6)), and the Faa4 (GenelD: 855288 (SEQ ID No: 7) encoding Protein ID - P47912 (SEQ ID No: 8)) in Saccharomyces cerevisiae; the FAA gene (GenelD: 2541350 (SEQ ID No: 9) encoding Protein ID - Q9P7D7 (SEQ ID No: 10)) in Schizosaccharomyces Pombe; the FAA gene (GenelD: 3257561 (SEQ ID No: 1 1 ) encoding Protein ID
- the enzymatic activity of the endogenous fatty acyl CoA synthetase (FAA), in the yeast or fungal species of the invention can be inhibited by means of inhibitors, for example with triacsin C (Pubchem. ID - CID: 9576787) or adenosine 5'-hexadecylphosphate.
- Triacsin-C can be added to the growth medium to inhibit FAA activity and thereby increase the levels of secreted fatty acids in the medium. This approach is useful in those cases where the FAA gene in the respective yeast or fungal species cannot be genetically modified.
- the gene encoding the fatty acid transporter, FATpl in the yeast or fungal species of the invention is disrupted or inhibited.
- Lipid metabolism is compartmentalized in Saccharomyces cerevisiae, whereby the biosynthetic enzymes are located in the cytosol of the cell, whereas the catabolic enzymes are located in peroxisomes and mitochondria.
- Fatty acid transporter FAT1
- Fat1 is a medium chain fatty-acid-CoA activase itself.
- a yeast or fungal strain of the invention is genetically modified by the transformation with and expression of a gene encoding Pyruvate-Formate lyase (pfl), which is an enzyme which converts pyruvic acid to acetyl-CoA and formic acid in the cytosol.
- PFL function in yeast requires expression of both the structural gene encoding the PFL homodimer (pfIB) and its activating enzyme (pfIA), and single electron donor as co-factor.
- Inactive PFL is converted into its active form under anaerobiosis by the stabilization of a glycyl radical in its active site, a process which is mediated by PfIA. S.
- Yeasts and fungi are eukaryotic organisms, in which many cellular processes are compartmentalization, such that the bulk of lipid-biosynthesis is located in cytosol, while catabolism is located in mitochondria and peroxisomes.
- Glycolysis which leads to production of pyruvate, is localised in the cytosol of yeast and fungi, while the conversion of pyruvate to acetyl CoA takes place in mitochondria catalysed by pyruvate dehydrogenase complex.
- the concentration of acetyl-CoA is relatively lower in cytosol than in mitochondria.
- the yeast or fungal strain of the invention that has been genetically modified to express pyruvate-Formate lyase (PFI A&B) (see point 2.2.1 above), will produce formate or formic acid in the cytosol.
- the yeast and fungal genome comprises a gene encoding formate dehydrogenase, which degrades formate to carbon dioxide and water, with production of an NADH molecule.
- formate dehydrogenase which degrades formate to carbon dioxide and water
- NADH NADH
- the fatty acid biosynthesis reaction consumes two NADPH, while growth on glycerol produces two NADH.
- the concentration of malonyl CoA in the modified yeast strain may be increased by over-expressing the ACC1 gene encoding an acetyl CoA Carboxylase which converts acetyl CoA into Malonyl CoA.
- enhanced expression/synthesis of acetyl CoA Carboxylase can be obtained by manipulating the expression levels of the native ACC encoding gene in its host cell, for example by substituting the native ACC gene promoter with an alternative promoter that directs higher expression levels of the cognate ACC gene.
- Over-expression of the ACC1 gene in yeast can, for example, by achieved by replacing the endogenous promoter of the native ACC1 gene with the TEF1 promoter from Saccharomyces cerevisiae [SEQ ID NO: 1 13].
- Suitable AAC1 genes to over-express include the ACC1 gene (GenelD: 855750 (SEQ ID No: 27) encoding Protein ID - Q00955 (SEQ ID No: 28)) in Saccharomyces cerevisiae; the ACC gene (GenelD: 2543344 (SEQ ID No: 29) encoding Protein ID - P78820 (SEQ ID No: 30)) in Schizosaccharomyces pombe; the ACC gene (GenelD: 8196923 (SEQ ID No: 31 ) encoding Protein ID - C4QXW1 (SEQ ID No: 32)) in Pichia pastoris; the ACC gene (GenelD: 8301221 (SEQ ID No: 33) encoding Protein ID - C5M4L7 (SEQ ID No: 34)) in Candida tropicalis; the ACC gene (GenelD: 2909424 (SEQ ID No: 35) encoding Protein ID - Q6CC
- the fatty acids secreted by the yeast or fungal species/strain of the invention is preferably shorter than 16 carbons in length, preferably 14 or 12 carbons in length.
- Fatty acid chain length is determined by the cytosolic enzyme, thioesterase (Acyl CoA-ACP Thioesterase), which cleaves the bond between growing fatty acid chain on the Fatty acid Synthase Complex (FAS) and releasing the fatty acid in the cytosol.
- thioesterase Acyl CoA-ACP Thioesterase
- Fatty acid chain thioesterase cleaves the thioester bond between Fatty acyl-CoA and Acyl-Carrier Protein (ACP) when the fatty acid chain reaches 16 Carbons in length.
- the yeast or fungal strain of the invention is genetically modified by transformation with a Acyl CoA-ACP thioesterase gene derived from any on of the following: Soyabean (Glycine max) GenelD: 100170693; Chlamydomonas reinhardtii (GenelD: 5722109 (SEQ ID No: 52) encoding Protein ID - A8HY17 (SEQ ID No: 53)); Arabidopsis thaliana (GenelD: 837372 encoding Protein ID - Q9SJE2 (SEQ ID No: 54)); Ricinus communis (GenelD: 8269197 (SEQ ID No: 55) encoding Protein ID - B9RAC3 (SEQ ID No: 56)); Triticum aestivum (GenelD: 543005); CtFatA from Brassica napus (Genbank accession number: X73849 (SEQ ID No: 57) encoding Protein ID - Q4
- tinctorius Genbank accession number: M96569 (SEQ ID No: 59) encoding Protein ID - Q42715 (SEQ ID No: 60)); GmFatAI from G. mangostana (Genbank accession number: U92876 (SEQ ID No: 61 ) encoding Protein ID - O04792 (SEQ ID No: 62)); CwFatBI from C. hookeriana (Genbank accession number: U17076 (SEQ ID No: 63) encoding Protein ID - Q39513 (SEQ ID No: 64)); CwFatBI from C.
- Saccharomyces cerevisiae (GenelD: 856010 (SEQ ID No: 71 ) encoding Protein ID - Q02891 (SEQ ID No: 72)); Pichia Pastoris (GenelD: 8196549 (SEQ ID No: 69) encoding Protein ID - C4QX24 (SEQ ID No: 70)) in a yeast strain of the invention can be achieved by replacing the native promoter of these genes with a stronger promoter.
- the release of free fatty acids in the cytosol and recycling of Coenzyme A is enhanced in a genetically modified yeast or fungal species of the invention by the heterogenous expression of the cytosolic mammalian Cytosolic Acyl CoA thioesterase (CTE).
- CTE Cytosolic Acyl CoA thioesterase
- a genetically modified yeast or fungal strain of the invention is transformed with a CTE gene derived from: Mus muscilis (GenelD: 26897 (SEQ ID No: 73) encoding Protein ID - 055137 (SEQ ID No: 74)); Arabidopsis thaliana (GenelD: 827955 (SEQ ID No: 75) encoding protein ID - Q5FYU1 (SEQ ID No: 76)); or Rattus norvegicus (GenelD: 170588 (SEQ ID No: 77) encoding Protein ID - Q6AZ44 (SEQ ID No: 78)).
- a CTE gene derived from: Mus muscilis (GenelD: 26897 (SEQ ID No: 73) encoding Protein ID - 055137 (SEQ ID No: 74)); Arabidopsis thaliana (GenelD: 827955 (SEQ ID No: 75) encoding protein ID - Q
- Free fatty acids may be converted to alkanes by treatment with a PD/C catalyst at 300°C and pressure 12 bars for 4 hours.
- Free fatty acids may be converted to alkanes by decarboxylation with immobilized enzymes, which may be prepared from extracts of cells comprising suitable enzymes such as the insects: Apis mellifera, Musa domestica, Zootermopsis angusticollis, Triatoma infestans which contain native long-chain fatty acid-decarboxylase for decarboxylation of fatty acids longer than 20 carbon in chain-length. Further suitable enzymes may be obtained from extracts of the algae: Crocosphaera spp, Isochrysis, Prymnesium spp, Ectocarpus spp, Laminaria spp, Streblonema spp.
- suitable enzymes such as the insects: Apis mellifera, Musa domestica, Zootermopsis angusticollis, Triatoma infestans which contain native long-chain fatty acid-decarboxylase for decarboxylation of fatty acids longer than 20 carbon in chain-length.
- suitable enzymes may be obtained from extracts of the
- the genetically modified yeast cells of the invention when grown on the modified growth medium of the invention are known to secrete fatty acids with chain- length longer than 20 carbon atoms.
- LCFAs Long-Chain Fatty acids
- the presence of Long-Chain Fatty acids (LCFAs) decreases the quality of the biodiesel by increasing its density and increasing the freezing point of the fuel-mixture, increasing their tendency to freeze in colder weathers.
- the LCFAs are decarboxylated enzymatically by the means of LCFA decarboxylases present in the extracts of various insects like "honey bee" (Apis mellifera), Wood-termite (Cootermopsis angusticollis), Triatoma etc.
- NCIM National centre for industrial microorganisms
- the effect of growth temperature was analysed by adjusting the temperature of the growth medium to a temperature ranging from 15 to 45°C, as indicated in Figures 1 a. In all other tested fermentation conditions the growth medium in the bioreactor was maintained at a temperature of 30 °C.
- the temperature Program Initial tempature 1 :100°C; hold 1 :2 min; rate 1 :10°C; temperature 2: 250°C; gold 2:25 min; Injection/Detector temperature: 250°C/250°C; carrier Flow: 30 ml/min; range: x10; attenuation: x1 ; 0
- Table 2 Fatty acids content of the sample measured by GC, where the peaks in the chromatogram ( Figure 2), can be compared with the values in the table. The value corresponding to the peak signifies the presence of that particular chain length fatty acid (given in last column of the table)
- fatty acid synthesis in micro-organisms adapts the membrane fatty acid profile (in particular its phospholipid content) in order to maintain its fluidity in response to changing growth temperature.
- Higher temperatures stimulate synthesis of longer chain FAs with a higher boiling point, while lower temperatures stimulate synthesis of lower chain length FAs with lower density and boiling point.
- the FAA2 gene was deleted Saccharomyces cerevisiae strain CEN-PK2 (MATa/MATa; ura3-52/ura3-52; trpl -289/trp1 -289; Ieu2-3,1 12/leu2-3,1 12; his3 D1/his3 D1 ; MAL2-8C/MAL2-8C; SUC2/SUC2) obtained from strain collection of CSM, and replaced with the 1 .1 kbp URA3 marker gene (derived from Kluyveromyces marxianus) conferring the capacity to synthesize uracil.
- URA3 encodes orotidine 5-phosphate decarboxylase (ODCase), an enzyme involved in the synthesis of pyrimidine ribonucleotides.
- Table 4 List of primers used for the purpose of gene deletion
- Primer set 1 upstream: SEQ ID NO: 93; downstream: SEQ ID NO: 94,
- Primer set 2 URA3 upstream flank fw: SEQ ID NO: 95; Rv: SEQ ID NO: 96, Primer set 3: FAA2 Fw: SEQ ID NO: 97; FAA2 Rv: SEQ ID NO: 98.
- WT-strain genomic DNA was extracted and subjected to Fusion PCR where the URA 3 gene was inserted in place of the deleted FAA2 gene.
- the yeast cells were transformed with URA3 according to protocol described by Gietz (Gietz, Jean et al. 1992). The transformed colonies were grown on SD-URA minimal medium plates. Colony PCR was conducted using Primer set 2, which clearly demonstrated the presence of the inserted URA3 gene and the loss of FAA2 gene in the mutant colonies. Stable mutant colonies were propagated on minimal media plates.
- aternatve car on sources g ycero , xyose, geste ce u ose an em ce u oses, mannitol and other sugar-alcohols, xylan.
- the fermentation conditions were multiphase comprising an initial 48 hours of aerobic growth, followed by 4 days of anaerobic conditions to facilitate the release of fatty acids into the medium.
- the flasks were incubated in a water- bath at 30 ° C and shaken at a speed of 80 rpm for efficient mixing. After 6 days fermentation, the OD of the culture was measured and the cells were then removed from the liquid phase by centrifugation at 5000 rpm for 6 minutes.
- the intra-cellular and extra-cellular fatty acids in the cells and the supernatant were extracted and quantified, according to Cocito and Delfini, 1994 supra. The only deviation from the protocol was that the extracellular fatty acids were extracted in the solvent diethyl ether instead of chloroform.
- GC conditions for analysis of fatty acids employed a DBI capillary column, (30 m long and 0.25 mm i.d; film thickness 0.25 ⁇ ), with a temperature gradient of 40°C to 200°C at 6°C/min; 200°C for 15 minutes; 200°C to 260°C at 6°C/min; 260°C to 290°C at 2°C/min; an injector temperature of 280°C; detector temperature of 300°C; a split rate of 1 :20; using the carrier gas helium; and linear flow-rate of 1 .5ml/min; pressure 15.7 psig; and an injection volume of 1 -2 ⁇ .
- the FAA2 gene was not detected in transformed colonies that were amplified with primer set 3 confirming the deletion of the FAA2 gene from the genome of the mutant yeast (wells 3-9, 11-17 in fig 6a, b).
- the URA3 gene was clearly detected in several of the mutants colonies (wells 25, 26, 8, 30-33 in Fig 6a, b) amplified with primer set 2 thereby demonstrating the Aura3 deletion event.
- the FAA2 deletion strain (FAA2Aura3) in Saccharomyces cerevisiae (AGPH-01) is deposited under the strain name CBS126804 with Centraalbureau voor Schimmelcultures, P.O Box 85167, 3508 AD Utrecht, NL on 26.04.2010 in conformity with rule 9.1 and 11.4(g) of the Budapest Treaty.
- the FAA2A-stain and WT-strain were grown on Modified Wickerham's synthetic media with the specified carbon source, and fatty acids were extracted from the growth medium and cells respectively as set out under (2.0.0)
- the Optical Density of the WT strain culture at the time of harvest was 11.
- the yield of fatty acids at the end of organic extraction of the culture medium was 5 ml per 50 ml of sampled culture medium.
- a crude sample of extracellularly secreted fatty acids, extracted from the culture medium, was separated by Gas-Chromatography and the components identified using Mass-Spectrometry (GC-MS).
- the GC-MS graph in figure 7 shows various peaks having retention times (RT) corresponding to components (mostly fatty acids) of the test-sample. All peaks corresponding to more than 4% of the secreted lipids are listed in Table 6.
- Table 6 Major extracellular fatty acids secreted by WT strain grown on 20% glucose.
- the yield of pure fatty acids secreted by the WT-stain yeast was approximately 67 ml per liter of culture. 2.2.2. Intracellular fatty acid profile of WT strain grown on 20% glucose
- the Optical Density of the WT strain culture at the time of harvest was 1 1 .
- the yield of intracellular fatty acids extracted from cells from a 50 ml of sample was 0.5ml.
- a sample of the extracted intracellular fatty acids was analysed by GC-MS.
- the GC-MS graph in figure 8 shows various peaks having retention times (RT) corresponding to components (mostly fatty acids) of the test-sample. All peaks corresponding to more than 4% of the secreted lipids are listed in Table 7.
- Table 7 Major intracellular fatty acids in WT strain grown on 20% glucose
- the Optical Density of the culture at the time of harvest was 7.
- the yield of saponifiable fatty acids at the end of organic extraction of the culture medium was 10 ml per 50 ml of sampled culture medium.
- a sample of the extracted extracellular fatty acids was analysed by GC-MS
- the GC-MS graph in figure 9 shows various peaks having retention times (RT) corresponding to components (mostly fatty acids) of the test-sample. All peaks corresponding to more than 4% of the secreted lipids are listed in Table 8.
- Table 8 Major extracellular fatty acids secreted by FAA2A strain grown on 20% glucose
- VLCFA Very Long Chain Fatty Acids
- the Optical Density of the FAA2A strain culture at the time of harvest was 7.
- the yield of intracellular fatty acids extracted from cells from a 50 ml of sample was 0.4ml.
- a sample of the extracted intracellular fatty acids was analysed by GC-MS
- the GC-MS graph in figure 10 shows various peaks having retention times (RT) corresponding to components (mostly fatty acids) of the test-sample. All peaks corresponding to more than 4% of the secreted lipids are listed in Table 9.
- Table 9 Major intracellular fatty acids secreted by FAA2A strain grown on 20% glucose.
- Table 10 Major extracellular fatty acids secreted by WT strain grown on 5% glycerol.
- the yield of pure fatty acids secreted by the WT strain was approximately 60 ml per liter of culture. 2.2.6. Extracellular fatty acid profile of FAA2A ura3 strain grown on 5% glycerol
- the yield of pure fatty acids (including siloxane) secreted by the FAA2A strain was approximately 32 ml per liter of culture (Table 12).
- Table 12 Yields of secreted fatty acids by WT-strain and FAA2A strain
- the FAA2A strain provides a 7%-8% increase in secreted pure fatty acids over the WT-strain, when grown on glucose as carbon source. When grown on glycerol, the yield of fatty acids decreases in both the FAA2A - and WT- stains, associated with a slower growth rate on this carbon source. The proportion of pure MCFAs secreted into the medium by the FAA2A strain was also increased by 16% over the WT-strain, if the VLCFA (tetratetracontane) produced by the WT-strain is excluded.
- the major MCFAs secreted by the FAA2A strain were palmitic acid (C:16:0) and stearic acid (C18:0) and oleic acid (C:18:1 ).
- the fatty acid-derivative of siloxane should be taken as the signal for the respective fatty acid in the original sample, due to a reaction between fatty acid esters in the sample with the stationary phase of the chromatography column.
- VLCFAs are solid fats and essentially unsuitable as biodiesel.
- the fatty acid elongase system (ELO1 , ELO2, ELO3) serves to elongate fatty acids of chain length 16 (MCFA) upward to 20-26 in Saccharomyces cerevisiae.
- MCFA chain length 16
- the high proportion of VLCFAs produced by the WT-strain suggests that the activity of the elongase system is elevated in presence of FAA2 gene. Deletion of FAA2 gene, surprisingly, stalls this loss of carbon into VLCFAs via the fatty acid elongase system.
- the FAA2 deletion causes carbon flux to be channelled away from VLCFAs towards secretion of MCFAs, indicating a key role in determination of chain-length of fatty acid in yeast.
- the maximum yield of fatty acids, directly suitable for biodiesel synthesis obtained from the FAA2A strain reached as high as 18- 20% from glucose.
- the yield of fatty acids per mole of glycerol was comparable, but slightly higher than for glucose.
- the growth conditions associated with anaerobic respiration lead to fatty acid secretion.
- deletion of the FAA2 gene in yeast serves to inhibit MCFA catabolism and channels carbon flux into MCFAs, and enhances secretion of the fatty acids of this medium chain length (predominantly palmitic (C:16:0), stearic (C:18:0 ) and oleic (C:18:1 ) acids) providing a modified yeast stain of the invention adapted for biodiesel production.
- Example 3 Use of Candida tropicalis for the production of fatty acids suitable for biodiesel
- Candida tropicalis (DTU stain collection) was grown on Modified Wickerham's synthetic media with the specified carbon source, and fatty acids were extracted from the growth medium and cells respectively as set out under (2.0.0).
- C. tropicalis grown on medium supplemented with either glucose or glycerol secretes the MCFA, palmitic acid, during the anaerobic fermentation phase.
- the yield of secreted palmitic acid is high, corresponding to 120ml/ litre of growth medium.
- C. tropicalis according to the present invention is a yeast stain that is particularly suited for biodiesel production.
- Over-expression of the ACC1 gene in yeast is achieved by replacing the endogenous promoter of the native ACC1 gene with the TEF1 promoter from Saccharomyces cerevisiae [SEQ ID NO: 1 13], in order to obtain ACC1 over-expression in a genetically modified yeast.
- a system for promoter replacement was based on a bipartite DNA molecule in which each of the two DNA fragments carries a target sequence, the sequence to be inserted, and a selectable marker gene, which is non-functional but homologous to some part of the same marker in the second fragment (Figure 15).
- the first fragment contains the upstream sequence of ACC1 , direct repeat and the upstream 2/3 Kluyveromyces lactis (Kl) URA3.
- the upstream which corresponded to the sequence in front of ACC1 promoter was amplified by primers ACC1 (SWA 3 and SWA4) using genomic DNA of wild type S. cerevisiae as a template.
- Direct repeat with the upstream 2/3 Kl URA3 was amplified from pWJ1042 as template with primers SWA5 and 6 (Table 13).
- Two PCR products were then fused together by primers SWA3 and 6.
- To obtain the second fragment three PCR products were generated.
- Direct repeat 2 SWA7 CTTGACGTTCGTTCGACTGATGAGC and Kl U RA3
- the pfIB, pfIA, genes are amplified ( Figure 17) using their respective 5' and 3' forward and reverse primers (Table 14).
- the genes are cloned by the "biobrick" assembly strategy of prefix and suffix insertions using the restriction enzymes EcoRI, Xbal, Spel, and Pstl.
- the final constructs consist of pGal1 -gene-Adh1_Terminator and are transferred into yeast Tet-off based shuttle vector PCM 182 and PCM 183 ( Figure 18). The assembly is then ready to be transferred to any yeast system for fatty- acid production.
- Primer PfIB forward - SEQ ID NO: 1 1 1 ; reverse - SEQ ID NO: 1 12.
- Yeast strains were grown on the defined growth medium given in Table 5 (Modified Wickerham Synthetic Medium), where the selected sole carbon source was 20% Glucose.
- the growth of the yeast strains, under fermentation growth conditions, and the subsequent extraction and analysis of extracellular lipids produced (fatty acid production) were as defined in Example 2.0.0.
- the extracted fatty acids were concentrated to a volume 2 ml and was sent for GC-MS analysis.
- the profile of fatty acids in the 2ml volume is set out in Table 15 and Figure 19.
- the double mutants in strains 4, 5, 6 and 7, produce fatty acids comprising an increasing proportion of shorter chain-length fatty acids.
- glycolytic pathway (glycerol » glyceraldehydes-3-phosphate) remains unused, thereby creating a NAD+ imbalance which hampers the growth of single mutants.
- introduction of PFL system relieves the cellular system of this NADH imbalance and thus, we see better performance by double mutant strains with PFL system.
- Yeast strains were grown on the defined growth medium given in Table 5 (Modified Wickerham Synthetic Medium), where the selected sole carbon source was 5% crude glycerol. The growth of the yeast strains, under fermentation growth conditions, and the subsequent extraction and analysis
- Crude glycerol includes other components that may either promote or inhibit growth and fermentation of the yeast strains.
- the single mutant strains 2 and 3 as well as the triple mutant 8 show the capacity to grow on crude glycerol and to produce more MCFAs than the WT strain.
- Strain 10 is also surprisingly robust in its capacity to grow and ferment crude glycerol to fatty acids.
- the importance of deletion of the FAA2 gene, and the activation of ACC1 gene for fatty acid production by fermentation on glycerol is also confirmed in the performance of strains 2, 3 and 8.
- Yeast strains were grown on the defined growth medium given in Table 5 (Modified Wickerham Synthetic Medium), where the selected sole carbon source was on 15% xylose.
- the growth of the yeast strains, under fermentation growth conditions, and the subsequent extraction and analysis of extracellular lipids produced (fatty acid production) were as defined in Example 2.0.0.
- the extracted fatty acids were concentrated to a volume 2 ml and was sent for GC-MS analysis.
- the profile of fatty acids in the 2ml volume is set out in Table 18 and Figure 22.
- the strains 3, 4 5, and 8 were out-performed the WT in utilizing xylose, and producing fatty acids. Again the PFL system contributes to this 5 enhanced capacity to produce fatty acids in the single, double and triple mutant strains.
- strain 8 The growth of the engineered yeast strains on digested lignocelluloses in the form of a wheat straw hydrolysate showed that the triple mutant strain (strain 8) produced more fatty acids than other engineered strains, while the single mutant FAA2 was also effective. Strain 8 however, has the additional advantage, compared to strain 2, in producing an even distribution of fatty acids of medium chain fatty acid range, important for biodiesel of the best quality. Furthermore, all of the fatty acids secreted by strain 8 are aliphatic, saturated fatty acids, while unsaturated fatty acids are distinctly present in the fatty acid profile of strain 2.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11725783.2A EP2582798A1 (de) | 2010-06-18 | 2011-06-20 | Herstellung von biodiesel mittels hefe aus lignocellulose und glycerin |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35634410P | 2010-06-18 | 2010-06-18 | |
EP10169839 | 2010-07-16 | ||
PCT/EP2011/060237 WO2011157848A1 (en) | 2010-06-18 | 2011-06-20 | Production of biodiesel by yeast from lignocellulose and glycerol |
EP11725783.2A EP2582798A1 (de) | 2010-06-18 | 2011-06-20 | Herstellung von biodiesel mittels hefe aus lignocellulose und glycerin |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2582798A1 true EP2582798A1 (de) | 2013-04-24 |
Family
ID=43067173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11725783.2A Withdrawn EP2582798A1 (de) | 2010-06-18 | 2011-06-20 | Herstellung von biodiesel mittels hefe aus lignocellulose und glycerin |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2582798A1 (de) |
CN (1) | CN103080305B (de) |
AU (1) | AU2011266953B2 (de) |
BR (1) | BR112012032279A2 (de) |
CA (1) | CA2802478A1 (de) |
WO (1) | WO2011157848A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2601292T3 (en) | 2010-08-06 | 2018-07-16 | Biopetrolia Ab | METHODS AND PRODUCTS FOR MANUFACTURING GROWERS |
PT2753701T (pt) | 2011-09-27 | 2018-08-10 | Exxonmobil Res & Eng Co | Acil-acp-sintases de éster ceroso |
EP2820029A4 (de) * | 2012-02-29 | 2015-12-23 | Exxonmobil Res & Eng Co | Vier-gene-signalweg für wachsestersynthese |
US8962299B2 (en) | 2012-02-29 | 2015-02-24 | Exxonmobil Research And Engineering Company | Four-gene pathway for wax ester synthesis |
DE102012207921A1 (de) | 2012-05-11 | 2013-11-14 | Evonik Industries Ag | Mehrstufiges Syntheseverfahren mit Synthesegas |
WO2015013674A2 (en) * | 2013-07-25 | 2015-01-29 | The Regents Of The University Of California | A yeast cell modified to overproduce fatty acid and fatty acid-derived compounds |
SI3110930T1 (sl) | 2014-02-28 | 2020-07-31 | Delft Advanced Biofuels B.V. | Postopek za ponovno pridobivanje lipidov ali ogljikovodikov |
CN105543301B (zh) * | 2016-01-08 | 2019-07-05 | 武汉科技大学 | 粗甘油与木质纤维素水解液共转化生产微生物油脂的方法 |
CN107384923B (zh) * | 2017-08-01 | 2020-12-01 | 齐鲁工业大学 | 启动子pYLG及其在构建高产长链二元酸的热带假丝酵母中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075136A1 (fr) * | 2000-03-31 | 2001-10-11 | Idemitsu Petrochemical Co., Ltd. | Production de lipides et de micro-organismes secretant des lipides |
WO2007136762A2 (en) * | 2006-05-19 | 2007-11-29 | Ls9, Inc. | Production of fatty acids and derivatives thereof |
CN101490241A (zh) * | 2006-05-19 | 2009-07-22 | Ls9公司 | 脂肪酸及其衍生物的制备 |
WO2008080124A2 (en) * | 2006-12-21 | 2008-07-03 | Gevo, Inc. | Butanol production by metabolically engineered yeast |
WO2008113041A2 (en) * | 2007-03-14 | 2008-09-18 | Ls9, Inc. | Process for producing low molecular weight hydrocarbons from renewable resources |
WO2008121701A1 (en) * | 2007-03-30 | 2008-10-09 | Cargill Inc. | Metabolic engineering of yeasts for the production of 1-butanol |
WO2009143495A2 (en) * | 2008-05-22 | 2009-11-26 | President And Fellows Of Harvard College | Fast-growing yeast |
-
2011
- 2011-06-20 CN CN201180029886.7A patent/CN103080305B/zh not_active Expired - Fee Related
- 2011-06-20 CA CA2802478A patent/CA2802478A1/en not_active Abandoned
- 2011-06-20 BR BR112012032279A patent/BR112012032279A2/pt not_active IP Right Cessation
- 2011-06-20 EP EP11725783.2A patent/EP2582798A1/de not_active Withdrawn
- 2011-06-20 WO PCT/EP2011/060237 patent/WO2011157848A1/en active Application Filing
- 2011-06-20 AU AU2011266953A patent/AU2011266953B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2011266953A1 (en) | 2013-01-17 |
CN103080305A (zh) | 2013-05-01 |
CA2802478A1 (en) | 2011-12-22 |
CN103080305B (zh) | 2014-12-24 |
AU2011266953A8 (en) | 2013-02-21 |
WO2011157848A1 (en) | 2011-12-22 |
AU2011266953B2 (en) | 2014-09-18 |
BR112012032279A2 (pt) | 2018-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011266953B2 (en) | Production of Biodiesel by yeast from lignocellulose and glycerol | |
Tai et al. | Engineering the push and pull of lipid biosynthesis in oleaginous yeast Yarrowia lipolytica for biofuel production | |
US9359581B2 (en) | Biotransformation using genetically modified Candida | |
US9862977B2 (en) | Engineered microbes and methods for microbial oil production | |
CA2901974C (en) | Method for producing ethanol using recombinant yeast | |
CN107709540B (zh) | 库德里阿兹威氏毕赤酵母ng7微生物及其用途 | |
US9879248B2 (en) | Engineered microbes and methods for microbial oil overproduction from cellulosic materials | |
US11142770B2 (en) | Isolated oleaginous yeast | |
WO2011008231A2 (en) | Biotransformation using genetically modified candida | |
US8999683B2 (en) | Production of biodiesel by yeast from lignocellulose and glycerol | |
Qian et al. | Valorization of crude glycerol into citric acid and malic acid by Yarrowia lipolytica | |
JP5817836B2 (ja) | 組換え酵母を用いたエタノールの製造方法 | |
CN113265343B (zh) | 一种重组多形汉逊酵母的构建方法及其应用 | |
WO2016162605A1 (en) | Enhanced diacid production with genetically modified micro-organisms | |
CN118146967A (zh) | 一种高效合成脂肪醇的菌株及其构建方法 | |
CN102869768B (zh) | 生产脂肪酸和脂肪酸衍生物的微生物工程 | |
CN102869768A (zh) | 生产脂肪酸和脂肪酸衍生物的微生物工程 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130116 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20140620 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20150904 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160115 |